<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Objective: To assess whether <z:chebi fb="11" ids="18295">histamine</z:chebi> type 2 receptor <z:chebi fb="68" ids="48706">antagonists</z:chebi> (H2RAs) improve overall survival when used as pre-, peri-, or postoperative therapy in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> who had surgical resection with curative intent </plain></SENT>
</text></document>